BRANFORD, Conn., Nov. 5 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that Dr. Timothy M. Shannon, President and Chief Executive Officer, will present a corporate update at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, November 12, 2008, at 3:15 p.m. Eastern time. The conference is being held at the New York Palace Hotel in New York, NY.
Access to a live webcast of the presentation will be available from the Investor Relations section of CuraGen's website at http://www.curagen.com. A replay of the webcast will be available after the presentation and archived for 90 days thereafter.
CuraGen Corporation (Nasdaq: CRGN) is a dedicated clinical-stage biopharmaceutical company developing diverse approaches for the treatment of cancer. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.
Vice President and Chief Financial Officer
Glenn Schulman, PharmD
Director of Medical Communications
|SOURCE CuraGen Corporation|
Copyright©2008 PR Newswire.
All rights reserved